Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-29.45	29.29	-41.51
Graham Fair Price	-67.27	0.82	2.52
PEG	29.96	0.06	-0.05
Price/Book	50.19	1.76	1.17
Price/Cash Flow	390.35	28.89	-5.89
Prices/Earnings	387.59	7.21	-1.48
Price/Sales	-67.26	1.18	3.60
Price/FCF	390.35	28.89	-5.89
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	125.38	0.19	0.08
Operating Margin	-86.25	0.08	-0.55
ROA	-79.68	< 0.005	-0.03
ROE	-0.20	0.06	-69.20
ROIC	-0.10	0.03	-66.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	3485.91
Dividends QOQ	0.06	0.06	1.78
EBIT QOQ	-4.84	1.37	-71.64
EPS QOQ	0.31	1.18	275.19
FCF QOQ	0.32	1.18	267.76
Revenue QOQ	-0.44	1.70	284.86
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1047.70	358.42	-65.79
Days Sales Outstanding (DSO)	763.80	272.60	-64.31
Inventory Turnover	0.09	0.25	192.31
Debt/Capitalization	0.49	0.61	25.62
Quick Ratio	0.15	0.18	15.80
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.19	0.70	-41.03
Cash	0.20	0.23	18.27
Capex	< 0.005	< 0.005	91.68
Free Cash Flow	-0.24	0.04	-81.94
Revenue	0.39	1.05	170.53
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.85	0.84	-1.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-17.10	12.51	-26.86
Naive Interpretation	Member

06 - Financial Health · Bad

Rating